SILO PHARMA, INC. Earnings Per Share (Basic)
SILO PHARMA, INC. (SILO) reported Earnings Per Share (Basic) of -$0.76 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- SILO PHARMA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.76.
- SILO PHARMA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.12.
- SILO PHARMA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.12.
- SILO PHARMA, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$2.88.
- SILO PHARMA, INC. earnings per share, basic for fiscal 2023 was -$1.20.
- SILO PHARMA, INC. earnings per share, basic for fiscal 2021 was $0.04.
- SILO PHARMA, INC. earnings per share, basic for fiscal 2020 was -$0.05.
- SILO PHARMA, INC. earnings per share, basic for fiscal 2018 was -$0.02, a 300.00% decline from fiscal 2017.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.76 10-Q · filed 2026-08-13 | -$2.46 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | -$0.50 POS AM · filed 2026-04-14 | ||||||
| 2025-09-30 | -$0.12 10-Q · filed 2025-11-13 | -$0.50 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | -$2.88 10-Q · filed 2026-08-13 | -$0.19 10-Q · filed 2025-08-13 | -$6.22 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | -$0.23 10-Q · filed 2026-05-14 | ||||||
| 2024-12-31 | -$1.19 POS AM · filed 2026-04-14 | ||||||
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-13 | -$0.78 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | -$0.31 10-Q · filed 2025-08-13 | -$0.59 10-Q · filed 2025-08-13 | |||||
| 2024-03-31 | -$0.28 10-Q · filed 2025-05-09 | ||||||
| 2023-12-31 | -$1.20 10-K · filed 2025-03-28 | ||||||
| 2023-09-30 | -$0.21 10-Q · filed 2024-11-12 | -$0.82 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | -$0.32 10-Q · filed 2024-08-13 | -$0.61 10-Q · filed 2024-08-13 | |||||
| 2023-03-31 | -$0.29 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | -$1.71 derived: net income ÷ weighted average shares · filed 2024-03-25 | ||||||
| 2022-09-30 | -$0.49 10-Q · filed 2022-11-10 | -$1.13 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | -$0.01 10-Q · filed 2022-08-01 | -$0.01 10-Q · filed 2022-08-01 | |||||
| 2022-03-31 | -$0.01 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | $0.04 10-K · filed 2022-03-28 | ||||||
| 2021-09-30 | $3.20 10-Q · filed 2022-11-10 | $0.06 10-Q · filed 2021-11-10 | $1.80 10-Q · filed 2022-11-10 | $0.04 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-01 | -$0.03 10-Q · filed 2022-08-01 | |||||
| 2021-03-31 | -$0.03 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | -$0.05 10-K · filed 2022-03-28 | ||||||
| 2020-09-30 | -$0.01 10-Q · filed 2021-11-10 | -$0.04 10-Q · filed 2021-11-10 | |||||
| 2019-09-30 | -$0.01 10-Q · filed 2019-11-13 | -$0.03 10-Q · filed 2019-11-13 | |||||
| 2019-06-30 | -$0.01 10-Q · filed 2019-08-13 | -$0.02 10-Q · filed 2019-08-13 | |||||
| 2019-03-31 | -$0.01 10-Q · filed 2019-05-14 | ||||||
| 2018-12-31 | -$0.02 10-K · filed 2019-04-04 | ||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 | -$0.01 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | -$0.01 10-Q · filed 2019-08-13 | -$0.01 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | ||||||
| 2017-12-31 | $0.01 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |